🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To demonstrate the efficacy of ranibizumab in combination with reduced-flue...
Status
Completed
Location
Multiple Locations
Start Date
2012-06
Trial ID
NCT01968486
Treatments Being Tested
In this pilot study the researchers will evaluate the safety and efficacy o...
Status
Completed
Location
Eagle Mountain Vision
Start Date
2007-05
Trial ID
NCT00473642
Treatments Being Tested
The purposes of this study is to determine if combination reduced fluence p...
Status
Withdrawn
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT00726973
Treatments Being Tested
This study evaluated the effect of combination therapy with verteporfin pho...
Status
Completed
Location
Novartis Investigative Site
Start Date
2007-02
Trial ID
NCT00436553
Treatments Being Tested
Ranibizumab has been proven to be effective in large multicentre studies. H...
Status
Completed
Location
Department of OPhthalmology Medical center east
Start Date
2007-03
Trial ID
NCT01570608
Treatments Being Tested
Optical Coherent Tomography Angiography (OCTA)-Directed PDT Triple Therapy ...
Status
Withdrawn
Location
Wake Forest Health Sciences
Start Date
2023-03-30
Trial ID
NCT04075136
Treatments Being Tested
Single agent anti-VEGF therapies such as ranibizumab have shown great promi...
Status
Completed
Location
California Retina Consultants & Research Foundation
Start Date
2007-05
Trial ID
NCT00527475
Treatments Being Tested